Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.

Zhao, Zhigang; Wang, Jingyao; Lei, Mengjie; Li, Yachao; Yang, Yanli; An, Lei; Sun, Xue; Li, Cairong; Xue, Zengming

Zhao, Zhigang; Wang, Jingyao; Lei, Mengjie; Li, Yachao; Yang, Yanli; An, Lei; Sun, Xue; Li, Cairong; Xue, Zengming.

Afiliação

Zhao Z; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Wang J; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Lei M; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Li Y; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Yang Y; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
An L; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Sun X; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Li C; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China.
Xue Z; Department of Cardiology, Langfang Core Laboratory of Precision Treatment of CAD, Langfang People's Hospital, Hebei Medical University, Langfang, No. 37, Xinhua Road, 065000, Langfang, China. xuezengming@163.com.

BMC Cardiovasc Disord ; 23(1): 168, 2023 03 29.

Article em En | MEDLINE | ID: mdl-36991321

Assuntos

Infarto do Miocárdio; Intervenção Coronária Percutânea; Infarto do Miocárdio com Supradesnível do Segmento ST; Humanos; Clopidogrel/efeitos adversos; Ticagrelor/efeitos adversos; Inibidores da Agregação Plaquetária/uso terapêutico; Infarto do Miocárdio com Supradesnível do Segmento ST/diagnóstico por imagem; Infarto do Miocárdio com Supradesnível do Segmento ST/terapia; Intervenção Coronária Percutânea/efeitos adversos; Estudos Retrospectivos; Infarto do Miocárdio/terapia; Infarto do Miocárdio/tratamento farmacológico; Hemorragia/epidemiologia; Prognóstico; Resultado do Tratamento

Palavras-chave

Bleeding; De-escalation; Dual antiplatelet; Major adverse cardiovascular and cerebrovascular events; Myocardial infarction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST / Infarto do Miocárdio Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google